UNIXELL
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
UNIXELL
Industry:
Biotechnology Medical
Founded:
2021-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
200 M CNY
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
KayoThera
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
Promedigen
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.
SonALAsense
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
Investors List
Fosun Pharma
Fosun Pharma investment in Seed Round - UniXell
GL Ventures LLC
GL Ventures LLC investment in Seed Round - UniXell
Kunlun Capital
Kunlun Capital investment in Seed Round - UniXell
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Seed Round - UniXell
Winfast Holding
Winfast Holding investment in Seed Round - UniXell
TF Capital
TF Capital investment in Seed Round - UniXell
CDH Investments
CDH Investments investment in Seed Round - UniXell
Kunlun Capital
Kunlun Capital investment in Angel Round - UniXell
GL Ventures LLC
GL Ventures LLC investment in Angel Round - UniXell
More informations about "UniXell"
UniXell Biotechnology Company Profile 2024: …
UniXell Biotechnology General Information Description. Developer of cellular therapy based on human pluripotent stem cells. The company focuses on unmet medical needs, including neurodegenerative diseases and rare diseases, and …See details»
UniXell - Funding, Financials, Valuation & Investors - Crunchbase
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
UniXell - Golden
Organization. Company attributes. Industry. Biotechnology. Technology. Biology. Location. Shanghai. Investors. CDH Investments. Fosun Pharma. Sherpa Venture Capital. Kunlun …See details»
UniXell Biotechnology Asset Profile - Preqin
Based in Shanghai, China and founded in 2021, UniXell Biotechnology is a developer of new generations of cell therapy drugs, focusing on the development of next-generation cell therapy …See details»
UniXell Biotechnology - Crunchbase Company Profile …
Organization. UniXell Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. UniXell Biotechnology is a new-generation cell therapy drug developer, …See details»
UniXell Biotechnology - Products, Competitors, Financials, …
UniXell Biotechnology provides pharmaceutical solutions with a focus on developing a new generation of cell therapy drugs based on human pluripotent stem cells. It offers a …See details»
Shanghai UniXell Biotechnology Co. Ltd. - BioCentury Company …
Shanghai UniXell Biotechnology Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
UniXell Biotech launches GMP production base - Pudong
Apr 12, 2023 UniXell Biotech launches GMP production base On April 8, Shanghai UniXell Biotechnology's production base at Good Manufacturing Practice level was officially put into …See details»
Shanghai UniXell Biotechnology Asset Profile | Preqin
Based in Shanghai, China, and founded in 2021, Shanghai UniXell Biotechnology operates as a biotechnology company that develops cell therapies for the treatment of various diseases. In …See details»
UniXell - Crunchbase
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»
China Digest: Nutshell raises $40m Series A+ round; UniXell closes …
Mar 14, 2022 A researcher at Shanghai UniXell Biotechnology is observing the growth condition of pluripotent stem cells under a microscope. Source: Shanghai UniXell Biotechnology. Eudora …See details»
UniXell DA-001 - Drug Targets, Indications, Patents - Synapse
UniXell DA-001, Initially developed by Shanghai Yusai Biotechnology Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System …See details»
BioCentury
Founded in 2021, Unixell has four key technology platforms: Stem Cell Reprogramming, Directed-differentiation, SISBAR pedigree tracing and High-precision gene editing. With these best-in …See details»
What is UniXell Biotechnology? Company Culture, Mission, Values
UniXell Biotechnology. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. …See details»
Seed Round - UniXell - 2022-03-14 - Crunchbase
Mar 14, 2022 Organization Name . UniXell . Announced Date Mar 14, 2022; Funding Type ...See details»
Working at UniXell Biotechnology - Glassdoor
See what employees say it's like to work at UniXell Biotechnology. Salaries, reviews, and more - all posted by employees working at UniXell Biotechnology.See details»
Angel Round - UniXell - 2021-08-01 - Crunchbase
Organization Name . UniXell . Announced Date Aug 1, 2021; Funding Type Angel; Funding Stage ...See details»
Unixell-Bioinformatics · GitHub
GitHub is where Unixell-Bioinformatics builds software. GitHub is where Unixell-Bioinformatics builds software. Skip to content. Navigation Menu Toggle navigation. Sign in UnixellTest. …See details»
Series A - UniXell Biotechnology - 2024-04-02 - Crunchbase
Apr 2, 2024 Organization Name . UniXell Biotechnology . Announced Date Apr 2, 2024; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. …See details»